SEC 13F Intelligence

Mpm Bioimpact LLC / CNTX

Mpm Bioimpact LLC’s Context Therapeutics Inc Position

Does Mpm Bioimpact LLC own Context Therapeutics Inc (CNTX)? Yes — 10.68M shares worth $28M (+2.16% of its 13F portfolio) as of Q1 2026.

Position Value
$28M
Q1 2026
Shares
10.68M
% of Portfolio
+2.16%
Quarters Held
6
currently held

Position History CNTX

Reported value by quarter
Q4 ’24: $15MQ4 ’24Q1 ’25: $9MQ1 ’25Q2 ’25: $10MQ2 ’25Q3 ’25: $14MQ3 ’25Q4 ’25: $16MQ4 ’25Q1 ’26: $28MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 202610.68M$28M+2.16%
Q4 202510.68M$16M+1.80%
Q3 202514.71M$14M+2.33%
Q2 202514.71M$10M+1.67%
Q1 202514.71M$9M+1.55%
Q4 202414.71M$15M+2.19%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Mpm Bioimpact LLC’s full portfolio or all institutional holders of CNTX.